The SURPASS-1 trial demonstrated significant improvements in glycemic control and substantial reductions in body weight with all three doses of tirzepatide (5 mg, 10 mg, or 15 mg) compared to placebo over a 40-week period
It works by mimicking a naturally occurring hormone, GLP-1, which increases insulin production, reduces appetite, and slows gastric emptying
Its eventual approval will likely make it accessible through prescription as a once-weekly injection, aligning with existing GLP-1 agonists
Potential antioxidant effects of Amuc_1409 In 2024, researchers employed nanoflow liquid chromatography-tandem mass spectrometry (nLC-MS/MS) to analyze the secreted proteome of A
If a dose is missed, it should be taken as soon as possible within four days